FindTrial
Sign In

The Clinical Study of the Use of Goal Controlled Procedural Sedation and Analgesia Strategy (GCPSA) in digestive endoscopy treatment

The Clinical Study of the Use of Goal Controlled Procedural Sedation and Analgesia Strategy (GCPSA) in digestive endoscopy treatment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042672
Enrollment
Unknown
Registered
2021-01-26
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive Endoscopy Treatment

Interventions

experimental group:Dex+Remifentanil
control group:Propofol+Remifentanil

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Surgery duration > 30min; 2. American Society of Anesthesiologists physical status classification I-II; 3. Male or female patients aged 18 to 65 years; 4. BMI < 30 kg/m2; 5. The ability to provide informed consent.

Exclusion criteria

Exclusion criteria: 1. Sesvere cardiac, pulmonary, hepatic or renal diseases; 2. Allergy to propofol, eggs, soybean, or albumin.

Design outcomes

Primary

MeasureTime frame
the incidence of hypoxemia;—

Countries

China

Contacts

Public ContactLiujiazi Shao

Beijing Friendship Hospital, Capital Medical University

shaoliujiazi@163.com+86 13426498734

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026